Clinical Trials Browser

Osteosarcoma

Neuroblastoma

Pancreatic Neoplasms, Stomach Neoplasms

Advanced Triple Negative Breast Cancer

Advanced Gastric Cancer

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Lymphoma, T-Cell, Peripheral

Triple Negative Breast Neoplasms

Stomach Neoplasms

Recurrence, Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

Small Cell Lung Carcinoma

Locally Advanced or Metastatic Gastric Adenocarcinoma

Colorectal Neoplasms

Hepatic Metastasis of Colorectal Cancer

Advanced Gastric Cancer

Advanced Gastric Cancer

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Carcinoma, Hepatocellular

Head and Neck Neoplasms

Stomach Neoplasms

Carcinoma, Hepatocellular, Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Liver Neoplasms

Clinical Trials

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer

Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

FUTURE

A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

A Study of Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Camrelizumab Combined With Apatinib 、XELOX 、RFA in the Treatment of Liver Metastases of Colorectal Cancer

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer

Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant

Y-HR2017-025

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

Dose-Escalation and Safety Trial of YN968D1

A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure

A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients